The ongoing shift in technology from analog to digital has significantly hampered growth prospects in the film and printing business. Significant exposure to silver costs. Recognizable brand name and strong market position in medical and dental film. Aggressive financial risk profile characterized by a sizable debt burden. Consistently good free cash flow generation. The outlook is stable. Standard&Poor's Ratings Services expects modest growth in Carestream Health Inc.'s digital products revenues to offset the gradual decline of the traditional film business. We expect that stable operating margins and disciplined capital spending will enable the company to continue to generate good free cash flow in excess of $100 million, and to maintain metrics appropriate for the rating. We could lower
